(Q41321983)

29 September 2017

1 reference

title

Detection of diuretic agents in doping control (English)

1 reference

29 September 2017

Ventura R

1

1 reference

29 September 2017

Segura J

series ordinal

2

1 reference

29 September 2017

publication date

1 December 1996

1 reference

Journal of chromatography. B, Biomedical applications

29 September 2017

published in

1 reference

29 September 2017

volume

687

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

127-144

1 reference

Diuretics. Clinical pharmacology and therapeutic use (Part I).

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Diuretics. Clinical pharmacology and therapeutic use (Part II).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacological classification and renal actions of diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

GLC Determination and Urinary Recovery of Bumetanide in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Diuretic effect and metabolism of bumetanide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Bumetanide and furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of bumetanide following intravenous, intramuscular, and oral administrations to normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

The Use of HPLC to Elucidate the Metabolism and Urinary Excretion of Furosemide and its Metabolic Products

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Clinical Pharmacokinetics of Frusemide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Effects of piretanide in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

A radioimmunoassay to measure piretanide in human serum and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of bendroflumethiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of the thiazide diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetic studies with chlorthalidone (hygroton�) in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Absolute bioavailability of chlorthalidone in man: A cross-over study after intravenous and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Absorption, metabolism, and excretion of hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of hydrochlorothiazide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Bioavailability of hydrochlorothiazide from tablets and suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Effects of formulation and food on the absorption of hydrochlorothiazide and triamterene or amiloride from combination diuretic products

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of spironolactone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Spironolactone. I. Disposition and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Spironolactone. II. Bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of triamterene and its metabolite in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Oral triamterene disposition

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Plasma and urinary levels of triamterene and certain metabolites after oral administration to man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Influence of advanced age on the disposition of acetazolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Diuretic therapy and exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Differential effects of sauna-, diuretic-, and exercise-induced hypohydration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

The influence of diuretics on the excretion and metabolism of doping agents - I. Mephentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

The influence of diuretics on the excretion and metabolism of doping agents part iv—caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

The influence of diuretics on the excretion and metabolism of doping agents--V. Dimefline

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Differential Potentiometric Method for Determining Dissociation Constants of Very Slightly Water-Soluble Drugs Applied to the Sulfonamide Diuretic Chlorthalidone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Liquid chromatographic screening of diuretics in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Comprehensive screening procedure for diuretics in urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Analysis of diuretic doping agents by HPLC screening and GC—MSD confirmation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Systematic analysis of diuretic doping agents by HPLC screening and GC/MS confirmation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Solid-Phase Extraction Techniques for Assay of Diuretics in Human Urine Samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Improved detection limits for screening of diuretics by coupled liquid chromatography and ultraviolet—visible spectrophotometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Comparison of derivatization procedures for the determination of diuretics in urine by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Column-switching techniques for screening of diuretics and probenecid in urine samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

High-performance liquid chromatographic determination of diuretics in urine by micellar liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Chromatographic monitoring of diuretics in urine samples using a sodium dodecyl sulphate—propanol micellar eluent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Estimation of diuretic drugs in biological fluids by HPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

High-performance liquid chromatographic behaviour of some pharmaceutically important thiazide, loop and potassium-sparing diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Retention reproducibility of thiazide diuretics and related drugs in reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Rapid high-performance liquid chromatographic determination with fluorescence detection of furosemide in human body fluids and its confirmation by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Drug testing at the 10th Asian Games and 24th Seoul Olympic Games.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Application of the extractive alkylation technique to the gas chromatographic determination of chlorthalidone in plasma in nanogram quantities

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Gas chromatographic determination of furosemide in plasma using an extractive alkylation technique and an electron capture detector

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Gas chromatographic determination of hydrochlorothiazide in plasma, blood corpuscles and urine using an extractive alkylation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Determination of chlorthalidone in plasma, urine and red blood cells by gas chromatography with nitrogen detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Determination of Plasma Hydrochlorothiazide Levels in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Extractive alkylation of sulphonamide diuretics and their determination by electron-capture gas chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Electron-Capture GLC Assay of Dichlorphenamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Analysis of bumetanide in human urine by high-performance liquid chromatography with fluorescence detection and gas chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Screening for diuretics in human urine by gas chromatography-mass spectrometry with derivatisation by direct extractive alkylation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Diuretic screening in human urine by gas chromatography-mass spectrometry: use of a macroreticular acrylic copolymer for the efficient removal of the coextracted phase-transfer reagent after derivatization by direct extractive alkylation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Negative-ion mass spectra of methylated diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

GLC Analysis of Hydrochlorothiazide in Blood and Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

GLC analysis of acetazolamide in blood, plasma, and saliva following oral administration to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

GLC determination of urinary chlorthalidone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

An Application of Mass Fragmentography to the Determination of Acetazolamide in Body Fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Detection of diuretics in horse urine by GC/MS

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Mass spectrometry of methyl and methyl-d3 derivatives of diuretic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Gas chromatographic determination of the high-ceiling diuretic ethacrynic acid and its thiol adducts in plasma of guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Determination and identification of amiloride in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Screening for diuretics in urine and blood serum by capillary zone electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Capillary zone electrophoresis for the rapid screening of banned drugs in sport

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Electron-impact mass spectrometry of diuretic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

Approach to the analysis of diuretics and masking agents by high-performance liquid chromatography-mass spectrometry in doping control

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2896%2900279-4

7 January 2021

10.1016/S0378-4347(96)00279-4

Identifiers

DOI

1 reference

29 September 2017

1 reference